Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SUMO modifies GβL and mediates mTOR signaling

Journal of Biological Chemistry(2024)10.1016/j.jbc.2024.105778Source: DataRank Database

SUMO modifies GβL and mediates mTOR signaling is a research paper published in Journal of Biological Chemistry (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.65)OA: goldTopics (40)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Uri Nimrod Ramírez-Jarquín ORCID,Neelam Shahani ORCID,Oscar Rivera ORCID,Manish Sharma ORCID,Preksha Sandipkumar Joshi

Live enrichment

PubMed:38395307 OpenAlex:https://openalex.org/W4392015055

NINDS

Grant: 1R21NS128564-01

Validating cGAS-STING pathway as drug target in Huntington disease mouse model

NINDS

Grant: R01NS128225

NINDS

Grant: R01-NS094577-01A1

NINDS

Grant: R01-NS087019-01A1

NSERC

Grant: RGPIN-2018-04193

Natural Sciences and Engineering Research Council of Canada

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01NS094577-03

Rhes-SUMO circuitry in Huntington's Disease Pathogenesis

National Institutes of Health

Grant: 5R01NS087019-03

mTOR Signaling in Striatum: Regulation and Function

National Institutes of Health

Grant: 3R01NS128225-02S2

Rhes-SUMO Pathway in Huntington disease

FWCI

0.65

Citation Percentile

0.6%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttp://www.jbc.org/article/S0021925824001546/pdf

publisherhttp://www.jbc.org/article/S0021925824001546/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925824001546?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925824001546?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jbc.2024.105778

Fields of Study

Metabolism, Diabetes, and CancerPancreatic function and diabetesPI3K/AKT/mTOR signaling in cancer0301 basic medicine03 medical and health sciences

MeSH Terms

mTOR Associated Protein, LST8 HomologHumansLysineUbiquitinsSignal TransductionSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinHEK293 CellsSumoylationTOR Serine-Threonine Kinases

Keywords

PI3K/AKT/mTOR pathwayCell biologySignal transductionChemistryBiologymTOR Associated Protein, LST8 HomologTOR Serine-Threonine KinasesLysineSUMO-1 ProteinSUMO isoformsSumoylationkinase signalingpost-translational modification; SUMO interactive motif; protein-protein interaction; kinase signaling; SUMO mechanism; SUMO isoforms; lysine-site regulation; nutrient signaling; amino acid stimulationnutrient signalingprotein-protein interactionHEK293 Cellspost-translational modificationlysine-site regulationSmall Ubiquitin-Related Modifier ProteinsSUMO mechanismamino acid stimulationHumansUbiquitinsSUMO interactive motifResearch Article